🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Donor Site

Donor Site Morbidity and Buccinator Muscle Integrity After Buccinator Myomucosal Flap Surgery in Patients With Velopharyngeal Incompetence NCT07853872n/a1 site📍 Sohag Sohag University · Tests: Bilateral posteriorly based buccinator myomucosal flap surgery Blue Light for Donor Site Healing in Burn Patients NCT07453927NA1 site📍 Cesena AUSL Romagna Rimini · Tests: Photobiomodulation with blue light Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds NCT05984628NA1 site📍 Fujian Fujian Medical University Union Hospital · Tests: human umbilical cord mesenchymal stem cells, blank solvent Pelashield vs Xeroform NCT07734519Phase 41 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: Pelashield, Xeroform HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant NCT03326921Phase 11 site📍 Seattle Fred Hutchinson Cancer Center · Tests: CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR, Bone Marrow Aspiration, Biospecimen Collection Donor Site Morbidity After Free Vascularized Fibular Graft NCT06324916n/a1 site📍 Asyut Assiut University · Tests: Xray αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) NCT06082947NA1 site📍 Columbus Nationwide Children's Hospital · Tests: CliniMACS® A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe. NCT07301866Phase 1, Phase 21 site📍 Montreal Ciusss de L'Est de l'Île de Montréal · Tests: ECT-001-CB Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease NCT03425526Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC NCT05669846Phase 21 site📍 Pittsburgh Diwakar Davar · Tests: Healthy Donor Fecal Microbiota Transplant (hdFMT), Pembrolizumab Liver Transplantation for Colorectal Cancer NCT07884110n/a1 site📍 Santiago Pontificia Universidad Catolica de Chile · Tests: Liver transplantation Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites NCT07057557NA1 site📍 Lahore King Edward Medical University · Tests: Aloe Vera Gel Dressing, Paraffin-Based Tulle Dressing Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies NCT03818334Phase 2, Phase 31 site📍 São Paulo Hospital Israelita Albert Einstein · Tests: Cyclophosphamide, ATG Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae NCT05757817NA4 sites📍 Montpellier📍 Nice📍 Toulouse Institut Claudius Regaud · Tests: Oropharyngeal or oral cavity reconstruction Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning NCT03852407Phase 210 sites📍 Antwerp📍 Bruges📍 Brussels University of Liege · Tests: Thymoglobulin, Melphalan, Fludarabine, Cyclophosphamid ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty NCT06753916Phase 212 sites📍 Irvine📍 Los Angeles📍 San Francisco Massachusetts Eye and Ear Infirmary · Tests: Corneal Donor Tissue with Cross Linking, Corneal Donor Tissue without Cross Linking Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies NCT06398457EARLY Phase 11 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Darzalex Faspro (Daratumumab and hyaluronidase-fihj), JH-DSA Semi-Quant Screen and Response Score Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery NCT04003038NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Negative Pressure Wound Therapy, Wound Care Management CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT NCT05943067Phase 1, Phase 22 sites📍 Tübingen📍 Tübingen University Hospital Tuebingen · Tests: CD45RA depleted donor lymphocyte infusion (DLI) Management of Postoperative Pain Following Free Gingival Graft Harvesting Using Ora-Aid Versus Acrylic Palatal Stent NCT07523802NA1 site📍 Cairo Cairo University · Tests: Ora-Aid Oral Wound Dressing, Acrylic Resin Palatal Stent Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) NCT05322850Phase 1, Phase 24 sites📍 Gainesville📍 Miami📍 Miami University of Florida · Tests: Orca-Q Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longus Tendon Autograft NCT07762989n/a1 site📍 Çankaya Gazi University · Tests: Anterior Cruciate Ligament Reconstruction Using a Peroneus Longus Tendon Autograft Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies NCT07285668NA1 site📍 Madison University of Wisconsin, Madison · Tests: Allogeneic donor TCRαβ+/CD19+ cell-depleted peripheral blood mononuclear cells CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk NCT07053462Phase 1, Phase 21 site📍 Beijing AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC · Tests: Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney, Kidney Transplantation with Standard Care Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies NCT06187870n/a1 site📍 Milan IRCCS San Raffaele · Tests: Collection of biological data The Effectiveness of Nano Bio Fusion Gingival Gel (NBF) on Wound Healing at the Palate (Donor Site) After Soft Tissue Graft Surgery Compared to Placebo Gel. NCT07330154NA1 site📍 Irbid King Abdullah University Hospital · Tests: Application of NBF gel after soft tissue graft surgery, Application of placebo gel after soft tissue graft surgery M-2018-334 in Hematological Malignancies NCT06225050NA1 site📍 Duarte Miltenyi Biomedicine GmbH · Tests: CliniMACS Prodigy® LP-TCRα/β-19-45RA (Trial Version) Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study NCT06337942NA1 site📍 Los Angeles University of California, Los Angeles · Tests: Bladder Transplantation, Combined Kidney and Bladder Transplantation Active Oxygen Gel Versus Hyaluronic Acid Gel for Palatal Wound Healing After Free Gingival Graft NCT07683351NA1 site📍 Ismailia Suez Canal University · Tests: Hyaluronic Acid gel, Active oxygen gel, Gelatin sponge with flowable composite Palatal Wound Healing After Free Gingival Graft Surgery NCT07409571NA1 site📍 Kahramanmaraş Kahramanmaras Sutcu Imam University · Tests: kollajen membran (Cytoplast™ RTMFOAM™, Osteogenics Biomedical Inc., Texas, ABD), triamcinolone acetonide
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy